Itamar Medical Appoints Brad Fluegel to its Board of Directors
May 24 2021 - 6:00AM
Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical
device and digital health company focused on the integration of
sleep apnea management into the cardiac patient care pathway, today
announced the appointment of Brad Fluegel to its Board of
Directors.
Mr. Fluegel’s vast experience includes wide ranging
leadership roles and 25+ years in the healthcare sector, primarily
in strategy and business development. Most recently, Mr. Fluegel
was Senior Vice President, Chief Healthcare Commercial Market
Development Officer for Walgreens Co. In this role he was
responsible for driving all commercial healthcare activities,
including sales and contracting, biopharma relationships, retail
clinics, clinical affairs, new service development and market
planning. Prior, he served as Walgreens’ Chief Strategy and
Business Development officer. Prior to Walgreens, Mr. Fluegel was
executive in residence at Health Evolution Partners. Earlier in his
career, he was Executive Vice President, Chief Strategy and
External Affairs Officer at Wellpoint (now Anthem) and as CEO for
Reden & Anders and Tillinghast-Towers Perrin, a clinical,
actuarial and management consulting practice serving all sectors of
the health care industry.
“We are delighted to welcome Brad to Itamar’s
board,” said Dr. Giora Yaron, Chairman of Itamar’s Board of
Directors. “His extensive and impressive experience working with
large scale international companies in the Direct to Consumer, or
DTC space, as well as the healthcare retail segment will serve as
an extraordinary resource for Itamar’s future growth plans.”
Mr. Fluegel currently serves on the Board of
Directors of Metropolitan Jewish Health System in New York City,
Performant Financial Corporation, Premera Blue Cross, Alight
Solutions and AdhereHealth.
Mr. Fluegel earned a master’s degree in public
policy from Harvard University and a bachelor’s degree in business
administration from the University of Washington.
About Itamar Medical Ltd.Itamar
Medical is a medical technology company focused on the development
and commercialization of non-invasive medical devices and solutions
to aid in the diagnosis of respiratory sleep disorders. Itamar
Medical commercializes a digital healthcare platform to facilitate
the continuum of care for effective sleep apnea management with a
focus on the core sleep, cardiology and direct to consumer markets.
Itamar Medical offers a Total Sleep Solution to help physicians
provide comprehensive sleep apnea management in a variety of
clinical environments to optimize patient care and reduce
healthcare system costs. The Company’s key product, WatchPATTM, is
commercially available within major markets including the US,
Japan, and Europe. Itamar Medical is a public company traded on the
Nasdaq and on the Tel Aviv Stock Exchanges, and is based in
Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For
additional information visit www.itamar-medical.com
Itamar Medical Investor Relations Contact
(U.S.)
Leigh Salvo Gilmartin GroupPhone:
+1-510-693-5238investors@itamar-medical.com
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Sep 2023 to Sep 2024